Related Experiment Video
Updated: May 18, 2026

08:31
Process of Making Three-dimensional Microstructures using Vaporization of a Sacrificial Component
Published on: November 2, 2013
Processing of degradable ulvan 3D porous structures for biomedical applications
Anabela Alves1, Rui A Sousa, Rui L Reis
1Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, University of Minho, Taipas, Guimarães, Portugal. anabela.pinto@dep.uminho.pt
Journal of Biomedical Materials Research. Part A
|September 12, 2012
Summary
Newly developed porous ulvan structures exhibit excellent water absorption and non-toxic degradation. These findings suggest ulvan biomaterials are promising for tissue engineering applications.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Tissue Engineering
Background:
- Ulvan, a polysaccharide, is gaining interest for biomedical applications.
- Novel biomaterials are needed for tissue engineering scaffolds.
Purpose of the Study:
- To design and characterize novel porous ulvan structures for biomedical use.
- To evaluate the physical, mechanical, and biological properties of these ulvan structures.
Main Methods:
- Fabrication of cross-linked porous ulvan structures.
- Assessment of mechanical performance, water uptake, and weight loss.
- Morphological analysis using scanning electron microscopy and microcomputed tomography.
- Evaluation of cell viability and proliferation to determine cytotoxicity.
Main Results:
- Ulvan structures demonstrated high water uptake (up to ~2000%) and a porous, interconnected morphology.
- The structures exhibited non-toxic degradation, supporting cell viability and proliferation.
- Mechanical properties, water absorption, and degradation profiles were characterized.
Conclusions:
- Cross-linked ulvan structures show potential as biocompatible scaffolds for tissue engineering.
- Further functionalization can enhance stability and biological interactivity for specific applications.
- Ulvan-based biomaterials offer a promising platform for regenerative medicine.

